-
. Keith Channon – a 5 year renewable award that underpins the work of the group. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of
-
analysis and is increasingly used in cancer research to uncover morphological features linked to disease pathology and severity. Similarly, molecular profiling through ‘omics technologies has provided new
-
data to build hypothesis and test them in laboratory models. You will contribute ideas for new research projects, collaborate in the preparation of scientific reports and journal articles and act as a
-
of focused ultrasound, animal models of pancreatic cancer, mouse surgery and immunological laboratory techniques. About You We are looking for an enthusiastic and motivated laboratory scientist who
-
proteome in heart-specific cell lines and primary tissue. It will utilize disease model systems to characterize unique cell surface signatures for cardiomyocytes, coronary endothelial cells, and fibroblasts
-
analyze the resulting datasets using biophysical modelling. A willingness to learn and employ biochemical approaches and interact with external collaborators in molecular biology and biochemistry
-
that requires accurate sub-grid models (e.g., Particle-in-Cell or Vlasov codes) coupled to a hydrodynamic simulation. In general, charged-particle transport is a non-trivial task, not only because of the large
-
genetic causes of neurological disorders and aim to develop therapies for such conditions with a high complementary approach, ranging from stem cell modelling to functional genomic. Enhancers play a pivotal